Market cap
$81 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
6.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -70.73 | -19.49 | 10.60 | -154.57 |
| Net Profit | -- | -213.98 | -90.16 | 9.85 | -192.26 |
| EPS | -- | -202.49 | -100.67 | 16.66 | 4.52 |
| Book Value | -- | -- | -- | -- | -8.14 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Mar-26 | Mar-25 | Mar-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 80.92 | -571.44 | -263.80 | 82.35 | 424.20 |
| Return on Capital
| 135.70 | -115.29 | -263.80 | 82.35 | 588.54 |
| Return on Assets
| -250.62 | -225.30 | -72.60 | -180.37 | -498.89 |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
-263.80
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-263.80
|
82.35
|
588.54
|
-853.70
|
-129.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-263.80
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-263.80
|
82.35
|
424.20
|
-2,968.58
|
-131.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-72.60
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-72.60
|
-180.37
|
-498.89
|
-279.28
|
-95.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-19.49
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-19.49
|
55.01
|
-20.34
|
-110.50
|
-50.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-90.16
--
Year on year growth in profit after tax
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-90.16
|
72.03
|
-26.77
|
-144.37
|
-61.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-1.01
--
Year on year growth in earnings per share
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-1.01
|
0.77
|
0.12
|
-0.72
|
-0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
--
|
--
|
--
|
-1.08
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
--
|
--
|
--
|
-1.08
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.43
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
2.43
|
0.40
|
0.21
|
0.72
|
3.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
--
|
--
|
--
|
0.69
|
3.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-17.87
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-17.87
|
-8.02
|
-14.95
|
-135.36
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
--
|
--
|
8.29
|
4.57
|
-20.47
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
410.43
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
410.43
|
999,564.98
|
174.01
|
41.71
|
10,236.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-6.73
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-6.73
|
-10.66
|
-2.92
|
-2.89
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
4.88
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
4.88
|
-9.04
|
-8.36
|
-18.71
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-4.68
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
OKYO Pharma Ltd ADR (OKYO)
|
-4.68
|
-6.86
|
-3.07
|
-2.80
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|